TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LFCR

Lifecore Biomedical Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

4.50$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Lifecore Biomedical Inc. (LFCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 129 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement LFCR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
539 541 532 524 558 160 101 186 111 128 129 129
474 470 449 446 477 121 62 135 72 86 89 89
65 71 83 78 81 39 39 50 39 42 40 41
7.0 7.2 9.5 13 11 7.6 6.7 7.8 7.8 8.6 8.3 8.5
47 56 51 63 72 65 46 42 43 44
47 57 68 65 76 65 48 54 51 51 58 42
18 -20 16 12 -8.0 -26 -8.8 -3.6 -12 -8.8 -17 -1.3
1.8 2.0 1.8 2.0 5.2 4.6 8.9 17 16 18 22 2.2
21 -19 15 16 3.6 -31 -30 -52 -21 9.5 -39 -30
7.7 -7.4 4.3 -9.4 1.5 -8.8 -6.4 -5.8 -5.2 0.2 0.0 0.6
14 -12 11 25 2.1 -38 -32 -97 -117 12 -39 -31
30 -7.8 27 25 23 -7.2 -1.0 -68 13 36 -8.8 8.2

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?